Related Experiment Videos
Phenytoin-induced thrombocytopenia.
1Department of Neurology, University of Wisconsin School of Medicine, Madison 53792.
Pediatric Neurology
|March 1, 1986
Summary
A 15-year-old boy experienced a rare side effect of phenytoin, developing thrombocytopenia and purpura. Symptoms resolved after discontinuing the medication, suggesting an autoimmune reaction to phenytoin.
Area of Science:
- Pharmacology
- Hematology
- Immunology
Background:
- Phenytoin is an anticonvulsant medication commonly used to treat epilepsy.
- Drug-induced blood dyscrasias are known but rare complications of various medications.
- Thrombocytopenia, a condition characterized by low platelet counts, can lead to bleeding.
Observation:
- A 15-year-old male patient presented with thrombocytopenia and purpura.
- These symptoms appeared two weeks after initiating phenytoin therapy.
- Elevated blood phenytoin levels were detected, falling within the toxic range.
Findings:
- The patient exhibited an increase in immature neutrophils, but other cell lines remained unaffected.
- Complete recovery of platelet count and resolution of purpura occurred upon discontinuation of phenytoin.
- The isolated nature of thrombocytopenia and the probable autoimmune etiology were noted.
Implications:
- This case highlights thrombocytopenia as a rare, potentially autoimmune complication of phenytoin therapy.
- Clinicians should consider phenytoin-induced thrombocytopenia in patients presenting with purpura and low platelets.
- Monitoring drug levels and prompt discontinuation of the offending agent are crucial for patient recovery.